For personal use only 2025 AUSTRALIAN RICE CONFERENCE Shaping the future Paul Serra SunRice Group CEO August 2025 2 0 2 5 A U S T R A L I A N R I C E C O N F E R E N C E Important notice & disclaimer This presentation has been prepared by Ricegrowers Limited (SunRice) and provides summary information only. SunRice has prepared this presentation in good faith believing the statements made in it to be true as at the date of the presentation. SunRice is not otherwise warranting the accuracy of the information ...

Equity Raising Overview - Silex is undertaking an equity raising of up to $130 million through a placement to eligible investors[11] - A share purchase plan (SPP) to eligible shareholders in Australia and New Zealand aims to raise up to $15 million[11] - The placement price is fixed at $3.90 per share, representing a 15.8% discount to the last close of $4.63 per share[42] and a 10.5% discount to the 5-day VWAP of $4.36 per share[42] - SPP shares will be issued at the lower of the placement price and a 2% discount to the 5-day VWAP up to the SPP closing date[42] Use of Proceeds - The proceeds from the offer, along with existing cash of approximately $69.6 million, will primarily support GLE's commercialization of the SILEX uranium enrichment technology in the US[41, 42] - Funds will also be used to pursue Silex's additional isotope production opportunities and strengthen the company's balance sheet[41, 42] - Silex expects to be fully funded through to the end of FY2028 following the placement[42] GLE Commercialization and Opportunities - GLE aims for commercial deployment of the SILEX uranium enrichment technology by 2030[40] - GLE's strategy includes potential production of UF6, LEU/LEU+, and HALEU at the Paducah Laser Enrichment Facility (PLEF)[41] - GLE has exclusive access to valuable uranium tails inventories from the US DOE, potentially producing up to 5 million lbs p a of natural grade uranium (as UF6) for up to 30 years[41, 74, 85]

For personal use only Bioshares Annual Conference Q&A presentation Hobart August 7, 2025 ® Xanamem is a registered trademark of Actinogen Medical Limited Disclaimer For personal use only Bioshares Q&A August 7, 2025 2 • This presentation has been prepared by Actinogen Medical Limited. ("Actinogen" or the "Company") based on information available to it as at the date of this presentation. The information in this presentation is provided in summary form and does not contain all information necessary to make a ...

Capital Raising and Financial Position - Liontown is undertaking a capital raising of approximately A$266 million to strengthen its balance sheet and provide a liquidity buffer[38, 42] - The pro forma cash balance after the capital raising is expected to be approximately A$422 million before transaction costs[42, 99] - The National Reconstruction Fund Corporation (NRFC) is investing A$50 million in Liontown as part of the capital raising at A$0.73 per share[42, 105] Operational Performance and Future Plans - In FY25, Liontown produced over 320,000 wmt of concentrate at 5.2% Li2O with 8% moisture, equivalent to over 294,000 dmt[38, 53] - Underground production stoping has commenced on schedule[38] - FY26 is expected to be a transition year for Kathleen Valley as underground production ramps up, with 100% underground production planned by Q3 FY26[42, 60] - A lithia recovery target of 70% by Q3 FY26 remains unchanged[42, 60] Financial Metrics and Guidance - FY25 revenue was A$301 million with an average realised price of A$1,061 per dmt (CIF) for ~SC5[53] - H2 FY25 unit operating cost was A$802 per dmt sold (FOB), and AISC was A$1,081 per dmt sold (FOB)[53] - FY26 concentrate production is guided at 365,000 - 450,000 dmt, with All in Sustaining Costs of A$1,060 - A$1,295 per dmt sold and Unit Operating Costs of A$855 - A$1,045 per dmt sold[61]

Financial Performance - Q2 2025 net sales reached $1.3 billion, aligning closely with the midpoint of the company's guidance range[12] - Adjusted EBITDA for Q2 2025 was $174 million, surpassing the company's guidance[12] - The company repaid $55 million in debt, including $50 million of 2025 Notes[12] - The company's gross profit margin increased by 10 bps year-over-year to 78%[31] - Adjusted diluted EPS was $0.59, which includes an $0.11 year-over-year foreign exchange headwind[31] Regional Performance - New distributor growth occurred in 4 out of 5 regions year-over-year, with Latin America leading at a 16% increase[12] - Worldwide net sales decreased by 1.7% year-over-year, but remained flat on a constant currency basis[34] - Latin America experienced a 9% increase in local currency net sales[34] Product Launches and Initiatives - The company launched the Herbalife Flex45 Challenge globally[12] - The company expanded the Diamond Development Mastermind Program to South and Central America[12] - The company launched MultiBurn, a multifunctional weight-loss supplement[12] - The company unveiled the beta version of the Pro2col digital platform[12] Future Outlook - The company projects net sales to increase between 0.5% and 4.5% year-over-year for Q3 2025[42] - The company anticipates adjusted EBITDA between $150 million and $160 million for Q3 2025[42] - The company expects full-year 2025 net sales to range from a decrease of 1% to an increase of 3% year-over-year[42]

Q2 2025 Financial Performance - Adjusted EPS reached $5.13, a 13% year-over-year increase, or 17% on a constant macro basis[10] - Revenues totaled $1.102 billion, up 13% year-over-year[10] - Adjusted EBITDA was $621 million, a 12% year-over-year increase[10] - The company reported organic revenue growth of 11%[10] - Revenue retention improved to 92.3%[10] Segment Performance - Corporate Payments revenue grew by 18%[10] - Vehicle Payments organic revenue growth was 9%[16] - Lodging Payments experienced a decline of 2%[16] - Other segments, including Gift and Payroll Cards, grew by 18%[16] Liquidity and Capital Allocation - Liquidity as of June 30, 2025, was approximately $3.5 billion[23] - Adjusted EBITDA was reported as $621 million[26] - Free cash flow generated was $366 million[26] - The company's leverage ratio was 2.53x[23] 2025 Guidance - The company projects second-half adjusted EPS to accelerate to $11.40, an 18% increase over the first half of 2025[32] - Organic revenue growth in the second half is expected to be 10%[32]

Q2 2025 Financial Performance - Revenue from continuing operations reached $191.5 million, a 13% increase year-over-year[16] - Operating income was $10.5 million, a significant 438% increase year-over-year[16] - Adjusted EBITDA from continuing operations increased by 14% to $22.7 million[16] - Adjusted earnings per share from continuing operations doubled, reaching $0.04[16] Fruit Snacks Growth and Capacity - Fruit snacks revenue experienced substantial growth, driving the need for additional capacity[18, 19] - Sales growth of fruit snacks was +42% (Q3 2024 vs Q3 2023) and +11% (Q2 2025 vs Q3 2024)[19] - The company is investing $25 million in new fruit snacks capacity, expected to increase production capacity by approximately 25% in 2026[43] 2025 Outlook - Revenue outlook raised to $805-$815 million, representing an 11%-13% growth compared to the previous year[34, 35] - Adjusted EBITDA outlook reaffirmed at $99-$103 million, indicating a 12%-16% growth[34, 35] - The company is targeting a year-end net leverage of 2.5x[34, 40] Capital Allocation - The company returned $1 million to shareholders through the repurchase of 163,000 shares in Q2[42] - $24 million remains available under the existing share repurchase authorization[42]

Financial Performance - DHI Group's 2024 revenue was $142 million, with bookings of $141 million[11] - The company's operating cash flow for 2024 was $21 million, and capital expenditures were $14 million[11] - Adjusted EBITDA for 2024 was $35 million, representing a 25% margin[14] - DHI Group repurchased $72 million in shares from 2020 through Q2 2025[14] Business Segments - ClearanceJobs' 2024 revenue was $54 million, with a compound annual growth rate (CAGR) of 16% from 2020 to 2024[42] - Dice's 2024 revenue was $88 million, with a CAGR of 2% from 2020 to 2024[45] - ClearanceJobs has 1900 subscription clients[43] - Dice has 4400 subscription clients[46] Q2 2025 Performance - ClearanceJobs' Q2 2025 revenue increased by 1% year-over-year[84] - Dice's Q2 2025 revenue decreased by 18% year-over-year[100] - ClearanceJobs' Q2 2025 Adjusted EBITDA was $61 million, with a margin of 45%[89] - Dice's Q2 2025 Adjusted EBITDA was $42 million, with a margin of 226%[107]

Q2 2025 Financial Performance - Systemwide sales increased by 6.7% to $154.2 million[8] - Sandwich shop sales, net, increased by 2.5% to $118.4 million[8] - Franchise royalties, fees, and rent income increased by 27.7% to $5.3 million[8] - Same-store sales increased by 3.2%[8] - Adjusted EBITDA increased by 13.0% to $9.6 million[8] - Shop-level margin increased by 10 basis points to 16.7%[24, 43] Strategic Growth Initiatives - The company is executing against a five-pillar strategic plan focused on traffic-driven profitability and unit growth[5, 6] - The Franchise Growth Acceleration (FGA) Initiative aims to drive unit growth through franchise development agreements and new openings[30] - The company has 816 open and committed shops, marking progress toward a 2,000 shop target, a 23% year-over-year increase[33, 34] Financial Outlook - The company expects Q3 2025 same-store sales to grow between 3.25% and 4.25% and adjusted EBITDA to be between $9.0 million and $10.0 million[38] - The company projects 2025 same-store sales growth between 2.0% and 3.0%, and adjusted EBITDA between $34 million and $35 million[39]

Company Overview - Symbotic is an AI-enabled technology platform transforming the supply chain[17] - The company's AI/software platform drives actionable insights from goods and location data to improve inventory optimization and order accuracy[19] - Symbotic has a transformative technology platform with 46 systems in deployment and 42 operational systems[22, 23] - The company has issued 650+ patents[23] Financial Highlights - Symbotic is experiencing YoY revenue growth of approximately 36%[23] - The company has a total backlog of $22.4 billion[23] - Symbotic is generating positive free cash flow[23] - In FY24, Symbotic's total revenue reached $1.788 billion, and adjusted EBITDA was $62 million[59, 62] - Symbotic reported a GAAP net loss of $84.672 million in FY24[62] Market Opportunity - The company is targeting large addressable markets, including a $432 billion one-time system sales opportunity in operator-owned warehouses[25, 26] - Symbotic has a $500 billion+ "outsourced" incremental annual warehouse-as-a-service opportunity through GreenBox[26]